iifl-logo

Hindustan Unilever Ltd Nine Monthly Results

2,498.6
(-0.75%)
Aug 8, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Financials

Particulars (Rupees in Crores.)Dec-2024Dec-2023Dec-2022Dec-2021Dec-2020

Gross Sales

46,842

45,925

44,596

38,058

34,081

Excise Duty

0

0

0

0

0

Net Sales

46,842

45,925

44,596

38,058

34,081

Other Operating Income

609

761

769

621

514

Other Income

1,151

580

352

182

301

Total Income

48,602

47,266

45,717

38,861

34,896

Total Expenditure

36,226

35,634

34,934

29,222

26,265

PBIDT

12,376

11,632

10,783

9,639

8,631

Interest

315

229

85

68

106

PBDT

12,061

11,403

10,698

9,571

8,525

Depreciation

1,008

896

846

813

808

Minority Interest Before NP

0

0

0

0

0

Tax

2,771

2,651

2,169

2,067

1,878

Deferred Tax

86

135

141

106

30

Reported Profit After Tax

8,196

7,721

7,542

6,585

5,809

Minority Interest After NP

11

2

22

10

0

Net Profit after Minority Interest

8,185

7,719

7,520

6,575

5,809

Extra-ordinary Items

328.49

-52.91

-110.24

-71.43

-190.45

Adjusted Profit After Extra-ordinary item

7,856.51

7,771.91

7,630.24

6,646.43

5,999.45

EPS (Unit Curr.)

34.84

32.85

32.01

27.98

24.72

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

2,900

1,800

0

0

0

Equity

235

235

235

235

235

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

26.42

25.32

24.17

25.32

25.32

PBDTM(%)

25.74

24.82

23.98

25.14

25.01

PATM(%)

17.49

16.81

16.91

17.3

17.04

Hind. Unilever: Related NEWS

HUL Cuts Prices of Key FMCG Products, But Skincare Gets Costlier
1 Aug 2025|02:25 PM

In addition to softer raw material costs, intensified competition in the FMCG space has played a role in prompting this pricing adjustment.

Read More
HUL Q1 Updates: PAT jumps 8% y-o-y to ₹2,732 Crore
31 Jul 2025|12:44 PM

On the other hand, EBITDA for the quarter stood at ₹3,718 Crore. This was marginally down against ₹3,744 Crore in the previous corresponding period.

Read More
Top Stocks for Today - 11th July 2025
11 Jul 2025|07:20 AM

Here are some of the stocks that may see significant price movement today: Tata Consultancy Services, IREDA, Glenmark Pharma, etc.

Read More
HUL Q4 Net Profit Rises to ₹2,493 Crore
25 Apr 2025|10:59 PM

HUL registered EBITDA of ₹3,466 crore in the March quarter, a 1% year-on-year increase. EBITDA margin for the quarter was 22.8%.

Read More
Top Stocks for Today - 22nd April 2025
22 Apr 2025|07:31 AM

Here are some of the stocks that may see significant price movement today: Brigade Enterprises, Coal India, Hindustan Unilever, etc.

Read More
HUL names Rajneet Kohli as executive director of foods business
27 Mar 2025|09:04 AM

As per the company, Kohli will take up the position on April 7, 2025, succeeding Shiva Krishnamurthy. He is leaving to pursue other opportunities.

Read More
Top Stocks for Today - 23rd January 2025
23 Jan 2025|07:09 AM

Here are some of the stocks that may see significant price movement today: Hindustan Unilever, BPCL, Persistent Systems, etc.

Read More
HUL Bypasses Distributors, Targets Kiranas Directly
31 Dec 2024|01:11 PM

Nearly 80% of FMCG sales in India are controlled by kirana stores, which are supplied by distributors or wholesalers.

Read More
Top Stocks for Today - 3rd December 2024
3 Dec 2024|07:22 AM

Here are some of the stocks that may see significant price movement today: Torrent Pharma, Hindustan Unilever, Nazara Tech, etc.

Read More
HUL Pays ₹192.55 Crore in Tax Demand Dispute
2 Dec 2024|08:19 PM

The dispute stems from an issue surrounding tax deduction at source (TDS) for a ₹3,045-crore payment HUL made to acquire intellectual property rights related to its India HFD business from GlaxoSmithKline (GSK).

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.